肺癌筛查 - 是时候更新了吗？
Lung cancer screening - Time for an update?
发表日期：2024 Oct
作者：
Henry M Marshall, Kwun M Fong
来源：
LUNG CANCER
摘要：
肺癌筛查可以降低肺癌的死亡率，肺癌是全球癌症死亡的主要原因。现实世界的筛查经验突出了复杂多变的世界中需要改进的领域，特别是种族差异，以及新出现的风险因素的潜力，以及众所周知的吸烟和石棉暴露风险。生物标志物有望进行客观风险评估，但尚未准备好用于临床实践。本综述讨论了肺癌筛查面临的一些主要问题以及生物标志物的潜在作用。版权所有 © 2024 作者。由 Elsevier B.V. 出版。保留所有权利。
Lung cancer screening can reduce the mortality of lung cancer, the leading cause of cancer death worldwide. Real world screening experience highlights areas for improvement in a complex and changing world, particularly ethnic disparity, and the potential for new and emerging risk factors, in addition to well known risk of smoking and asbestos exposure. Biomarkers offer the promise of objective risk assessment but are not yet ready for clinical practice. This review discusses some of the major issues faced by lung cancer screening and the potential role for biomarkers.Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.